Array Technologies Inc
(NASDAQ: ARRY)

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. The drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target pathways. The Company�s drug candidates include AMG 151, MEK162, ARRY-380, ARRY-520, ARRY-543 and ARRY-614.

7.040 -

+0.110 (+1.59%)
Range 7.010 - 7.220   (3%)
Open 7.130
Previous Close 6.930
Bid Price 7.020
Bid Volume 725
Ask Price 7.060
Ask Volume 100
Volume 264,865
Value 1,513,020
Remark -
Delayed prices. Updated at 16 Mar 2026 21:50.
Data powered by
View All Events

About Array Technologies

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. The drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target pathways. The Company�s drug candidates include AMG 151, MEK162, ARRY-380, ARRY-520, ARRY-543 and ARRY-614.

Loading Chart...

Please login to view stock data and analysis